Diageo Shells Out $81M To Settle Aussie, NZ Thalidomide Suits
Law360, New York (December 2, 2013, 5:00 PM EST) -- Diageo PLC agreed Monday to pay AU$89 million (US$81 million) to settle class action claims brought by Australians and New Zealanders with birth defects allegedly caused by the morning sickness drug thalidomide.
The U.K.-based alcohol producer's agreement resolves two class actions brought in Australian court on behalf of more than 100 people who suffered birth defects and other injuries after their mothers took thalidomide during pregnancy, according to the law firms Slater & Gordon and Gordon Legal, which represent the victims.
Distillers Co. Ltd., which was later acquired by Diageo, distributed the drug in Australia and New Zealand around 1960 and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!